indicatii prezentari

7/28/2019 indicatii prezentari

1/13

Common PowerPoint

Mistakes

The Bad & The Ugly

Presented by the AAAAI Medical

Informatics Committee


2/13

Patient Characteristics

Characteristics Minimum Maximum Mean SEM

Age, yr 40 78 63.4 1.2

Pack-yr 14.5 196 53.8 4.8

Peak flow, L 70 420 256 10

FEV1, L 0.64 2.7 1.39 0.064

FEV1, % pred 23 75 47.9 1.8

FEV1/FVC, % 25 70 49 0.01

Reversibility -2.5 17.1 10.4 1.69

FEF25-75 8.2 30.4 17.0 1.0

Kco, % 17.8 110.0 53.9 3.0


3/13

Infectious DiseasesInfectious diseases in which isolation from BAL is diagnosticPneumoc yst is car in i i

Toxo plasma gondi iStrongylo ides

Legionel la

Histoplasma

Mycob acter ium tuberculosis

Mycoplasma

Influenza

Respiratory syncytial virusInfectious diseases in which isolation from BAL is nondiagnostic but may contributeto the diagnosis and managementHerpes simplexCytomegalovirusBacteria

Aspergi l lusCandida

Cryptococcus

Atypical mycobacteriaNoninfectious DiseasesNoninfectious diseases in which analysis of BAL can be diagnosticAlveolar proteinosis

Eosinophilic granulomaCancer


4/13

Infectious DiseasesNoninfectious Diseases

Noninfectious diseases in which analysis of BAL can be diagnostic

Alveolar proteinosisEosinophilic pneumonia

Berylliosis

Hypersensitivity pneumonitis

Asbestosis

Silicosis

Sarcoidosis

Noninfectious diseases in which BAL findings may be helpful in the management

Idiopathic pulmonary fibrosis

Collagen vascular disease

Sarcoidosis


5/13

Pathogenesis of a BAD SLIDE that is

too crowded and confusing

Inconsistent

Labels

Misplaced arrows that not exactly on target

?LabelOverColored

Difficult use of colorThat doesnt clarify

InconsistentLabel

How is this

connected

Poor Box

Boxed Text That Goes Out

Of The Box

Total Confusion Hinders Presentation

Inconsistent Label

V

ER

T

I

C

A

L

Useful Information Related information that is not connected to anything


6/13

Magic Key Question 23a: Does Chronic Use

of ICSs and Daily Bronchodilators

Improve Long-Term Outcomes forChildren With Mild-to-Moderate Asthma?

Compared with inadequate therapy they improve

asthma control

Evidence does not suggest that the therapy improveslong-term postbronchodilator FEV1

No alternative long-term controller medicationappears superior to the therapy


7/13

Expert Panel Report 2:

Evaluating Severity Severity grading enhances the effectiveness

of initial asthma therapy

The presence of one of the features ofseverity is sufficient to place a patient inthat category. (EPR-2)

Treated patients should be categorizedbased on the pharmacotherapy required tokeep them well


8/13

Pharmacokinetics of Intranasal Steroids


9/13

Hanania et al. Chest. 1994;105:111-116.

Medical Staffs Ability to Effectively

Demonstrate Proper Inhaler

Techniques

0

20

40

60

80

100

MDI DPI MDI plus

AeroChamber

97*

82

6960*

12

21

98*

78

57

Mean

Score

(%)

*P


10/13

Title:

THIS PRESENTATION WAS DESIGNED TO SHOW

HOW NOT TO PRESENT POWERPOINT DATA (ORDATA DISPLAYED BY ANY OTHER COMPARABLE

SOFTARE APPLICATION) AND THE EXAMPLES

PRESENTED HERE SHOULD BE TAKEN AS AGOOD

(BAD?) EXAMPLES OF HOW NOT TO PREPARE

YOUR TALK IN A MANNER THAT WILL BE

USABLE AND READABLE BY THE AUDIENCE; the

authors of this presentation will accept no responsibility

for your evaluations if you copy these slides exactly as we

have developed them

Doctor James A. Doctor, H.S.G, B.A., M.D.

East Lake, Ohio

July 1, 2004


11/13

Cartoon to Wake You

Up


12/13


13/13

The END

indicatii prezentari

Documents